FLUDARA

This brand name is authorized in Australia, Canada, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Turkey, UK.

Active ingredients

The drug FLUDARA contains one active pharmaceutical ingredient (API):

1
UNII 1X9VK9O1SC - FLUDARABINE PHOSPHATE
 

Fludarabine is a water-soluble fluorinated nucleotide analogue of the antiviral agent vidarabine 9-β-D-arabinofuranosyladenine (ara-A) that is relatively resistant to deamination by adenosine deaminase. Fludarabine phosphate is rapidly dephosphorylated to 2F-ara-A which is taken up by cells and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2F-ara-ATP. This metabolite has been shown to inhibit ribonucleotide reductase, DNA polymerase α/δ and ε, DNA primase and DNA ligase thereby inhibiting DNA synthesis.

 
Read more about Fludarabine

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 FLUDARA Film-coated tablets MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 FLUDARA Powder for solution for injection or infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
L01BB05 Fludarabine L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BB Purine analogues
Discover more medicines within L01BB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 9184J
CA Health Products and Food Branch 02246226
EE Ravimiamet 1596551, 1722361
FI Lääkealan turvallisuus- ja kehittämiskeskus 395342, 524399
FR Base de données publique des médicaments 61324127, 62751438
GB Medicines & Healthcare Products Regulatory Agency 43555, 43557, 48463
HK Department of Health Drug Office 50447
IE Health Products Regulatory Authority 88247, 88249
JP 医薬品医療機器総合機構 4229002F1022, 4229400D1033
LT Valstybinė vaistų kontrolės tarnyba 1004848, 1004849
MT Medicines Authority MA596/00301, MA596/00302
NL Z-Index G-Standaard, PRK 61379
NZ Medicines and Medical Devices Safety Authority 10472
PL Rejestru Produktów Leczniczych 100145391
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W56210001, W56210002
SG Health Sciences Authority 11143P
TR İlaç ve Tıbbi Cihaz Kurumu 8699809098312, 8699809779167
ZA Health Products Regulatory Authority 28/26/0605, 36/26/0422

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.